IgniCognition 2023 Clinical Study

Concordia University Study (Montreal, Canada)

Taking IgniCognition for 30 days significantly outperformed both placebo and unenhanced supplement:

<< Back to Product Overview

Igniton

Igniton (eNPQ quasi-particle) technology was originally developed in the 1990’s, and in 1995 the lab was established at CERN facility (Switzerland) with much of the hardware to verify and measure the eNPQ quasi-particle named “ignitons” rented from CERN. The current operation is in Colorado.

The component stages of the eNQP (Ignitons) characterization system are from the Swiss laboratories, that were used until two years ago, when the necessary data on the nature of the quasi-particles and their industrial application had been collected, and the current equipment was designed, constructed and established in Colorado.

Ignitons, like neutrinos, are neutral quasi-particles. In addition to being extremely small, they have no electrical charge. Igniton size and velocity are similar to neutrinos. Ignitons as the life force was known from the time of Khem (ancient Egypt) and referred to as the World Spirit. The life of the original prokaryote bacteria on Earth were solely dependent on their ability to attract and capture ignitons.

Igniton currently focuses on improving longevity, cognition, memory, neuronal speed, reaction time, stimulating the pineal gland, etc. The quantum interaction between protons and ignitons allow for ignitons to disperse geometrically on the proton’s peripheral gray region, and improve quantum energy and functionality of targeted molecules.

University studies published in peer-reviewed medical journals show significant improvement of memory and other cognitive functions within 30-60 days of exposure.